Oura Acquires Medical AI Startup Counsel Health for $625 Million to Revolutionize Primary Care
Oura acquires medical AI startup Counsel Health for $625M, integrating wearable data with clinical AI to transform primary care and expand access to physicians.
S
··2 min readSciTech Editorial Team
Newsroom

In a strategic move that signals a significant shift in the consumer health technology landscape, Oura has announced its agreement to acquire Counsel Health, an AI-native primary care startup, for $625 million. The acquisition, revealed alongside Oura’s quarterly earnings, marks a pivotal moment in the convergence of wearable technology and clinical medicine. By integrating Counsel’s AI chatbot capabilities into its existing ecosystem, Oura aims to transform routine doctor visits into data-driven consultations that begin with a comprehensive readout of the user’s biometric data. This deal is expected to close before the end of the year, positioning Oura as a dominant force in the emerging market of digital primary care.
Counsel Health distinguishes itself as an "AI-native primary care company," leveraging artificial intelligence to generate insights and responses based on health data reported from wearables. The platform allows users to engage in initial AI-generated conversations that can seamlessly transition to interactions with in-house physicians. Oura CEO Tom Hale emphasized in an interview with Bloomberg that this acquisition is central to a broader plan to connect wearables, clinical AI, and direct access to doctors. The system is designed to answer medical questions and monitor ongoing conditions by drawing directly on the biometric data collected from Oura rings and other wearables, thereby personalizing the healthcare experience for each individual.
The strategic roadmap outlined in the press release focuses on three critical areas of healthcare: preventative care, acute care for episodic health concerns, and specialty and chronic care, particularly in domains such as reproductive and cardiometabolic health. This tripartite approach aims to address the full spectrum of user needs, from daily wellness monitoring to the management of complex, long-term conditions. By embedding these services within the Oura app, the company seeks to lower barriers to entry for medical consultations, making expert advice more accessible and immediate for its user base.
As part of the deal, Counsel Health’s 70 employees will join Oura, with Counsel CEO Muthu Alagappan assuming the new role of Chief Clinical AI Officer. According to Bloomberg, Alagappan indicated plans to expand the network of on-demand physicians, which currently consists of approximately 50 doctors. This expansion is crucial for scaling the service and ensuring that the AI-driven insights are backed by robust human medical oversight. Furthermore, Counsel will continue to offer its medical AI platform to external enterprise partners, including health plans, health systems, consumer health organizations, and employers, thereby diversifying revenue streams and broadening the reach of its technology beyond the Oura ecosystem.
This acquisition underscores a broader industry trend where consumer tech giants are venturing into regulated healthcare spaces. By combining the continuous data stream from wearables with the diagnostic and advisory capabilities of clinical AI and human physicians, Oura is positioning itself to redefine what it means to be proactive about one’s health. The integration promises to create a closed-loop system where data collection, analysis, and intervention are seamlessly connected, potentially reducing the burden on traditional healthcare systems while improving patient outcomes through personalized, data-informed care.



